Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2026-06-12

EMA Authorised: Amlodipine / Valsartan Mylan (amlodipine besilate;valsartan) — Mylan Pharmaceuticals Limited

View source ↗

Summary

Amlodipine besilate/valsartan combination (Amlodipine besilate; valsartan) by Mylan Pharmaceuticals Limited has been authorised for hypertension in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besilate/valsartan (amlodipine besilate; valsartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Mylan Pharmaceuticals Limited. Decision date: 08/06/2026